Line 184: | Line 184: | ||
<div class="mainbody" > | <div class="mainbody" > | ||
<p><b style="font-size:25px">Detection of CIP by HPLC-UV</b></p> | <p><b style="font-size:25px">Detection of CIP by HPLC-UV</b></p> | ||
− | Considering the sensitivity and accuracy of High Performance Liquid Chromatography (HPLC) tandem UV detector, we chose HPLC to monitor the degradation of CIP by CrpP. A standard curve of | + | Considering the sensitivity and accuracy of High Performance Liquid Chromatography (HPLC) tandem UV detector, we chose HPLC to monitor the degradation of CIP by CrpP. A standard curve of ciprofloxacin was established by HPLC-UV (Fig. 6) according to the procedure described in literuare [3]. Within the range of 50 – 300 μg/L, the CIP concentration and the peak area showed a good linear relationship. |
</div> | </div> | ||
Revision as of 12:10, 21 October 2019
Pathway construction
No. | Vector | E.coli resistance | Description |
---|---|---|---|
1 | piGEM2019-01 | Amp | PtisAB+LuxI+GFP+AmpR+ori+J23119+QnrS |
2 | piGEM2019-02 | Kan | PLuxR+PelB-5D+CrpP+TagRFP+J23100+LuxR+KanR+p15Aori |
3 | piGEM2019-03 | Amp | J23100+YF1+FixJ+Ter+PFixK2+Lysep3-D8+Ter+AmpR+ori |
(a) piGEM2019-01 digested by XbaⅠ+ VspⅠ (lane 1), piGEM2019-01 digested by SalⅠ+ VspⅠ (lane 2);
(b) piGEM2019-02 digested by SalⅠ+ KpnⅠ (lane 1), piGEM2019-01 digested by Hind Ⅲ + SacⅠ (lane 2);
(c) piGEM2019-03 digested by NdeⅠ+ BamHⅠ (lane 1).
Ciprofloxacin detection
qnrS1 — CIP resistance gene
E.coli DH5α carrying piGEM2019-01 was used to detect ciprofloxacin and produce AHL to activate piGEM2019-02. In order to achieve the better detection function, our detection bacteria must survive in a relatively high concentration of CIP. So, we added a ciprofloxacin resistance gene — qnrS1. We tested qnrS1 by adding gradient concentrations of CIP and measuring the growth curve (Fig. 2).
Moreover, we defined the Relative Bacterial Density to represent the resistance ability of qnrS1. The higher the Relative Bacterial Density is, the stronger the resistance will be. When the value was less than 1, it meant that the growth was suppressed. And we chose the experimental data of 1 mg/L CIP to analyze the Relative Bacterial Density defined above (Fig. 3). It could be seen intuitively from Fig. 3 that E.coli DH5α carrying piGEM2019-01 grew normally. Meanwhile, the values of control were all less than 1. It could be concluded that qnrS1 enhanced the viability of E.coli DH5α carrying piGEM2019-01 in CIP.
PtisAB — CIP responding promoter
Whether piGEM2019-01 actually has detection function depends on whether PtisAB responds to CIP. The expression of PtisAB can be detected by green fluorescence intensity. Fluorescence intensity was tested at different CIP concentrations(Fig. 4) [1]. The results showed that the fluorescence intensity in E.coli DH5α carrying piGEM2019-01 was significantly stronger than control, implying that PtisAB responded to CIP.Besides, we could infer the concentration of ciprofloxacin from the green fluorescence intensity. At a concentration of 0 – 1 mg/L of ciprofloxacin, it followed the formula y = 0.3698x + 0.5477. R2 = 0.9721 (y: the green fluorescence intensity; x: the ciprofloxacin concentration).
Ciprofloxacin Degradation
Detection of CIP by HPLC-UV
Considering the sensitivity and accuracy of High Performance Liquid Chromatography (HPLC) tandem UV detector, we chose HPLC to monitor the degradation of CIP by CrpP. A standard curve of ciprofloxacin was established by HPLC-UV (Fig. 6) according to the procedure described in literuare [3]. Within the range of 50 – 300 μg/L, the CIP concentration and the peak area showed a good linear relationship.Degradation of CIP by CrpP (HPLC-UV detection)
Then we co-transformed piGEM2019-01 and piGEM2019-02 into E.coli DH5α, and transformants were selected on LB agar plates using ampicillin and kanamycin. Overnight cultures of E. coli DH5α (piGEM2019-01 + piGEM2019-02) were diluted into 25 mL of fresh LB medium and were cultured at 37°C. When the culture was shaked for 1.5 hours, we added 1 mg/L CIP to induce the expression of CrpP, and the culture was incubated for additional 12 hours. Cells were harvested by centrifugation, and the pellets were suspended in 5mL PBS Buffer (pH = 7.4). Then the mix was treated with sonication. We used the cell extracts to degrade CIP, but it was difficult to tell the difference between experimental group (CrpP+) and control group (CrpP-) directly through peak shape in such a low CIP concentration.In order to solve the problem mentioned above, statistics methods were introduced. Same concentration of CIP was incubated in both groups in a 1.9mL mix including 2 mM ATP, with or without cell extracts that contain CrpP, at 37℃ for 30 minutes. Reaction was terminated by adjusting pH to about 2 (by adding Concentrated Hydrochloric Acid). It is reasonable to reckon that the average concentration of CIP of both groups has no difference in the beginning, but we can clearly notice that the experimental group's average concentration is lower than that of control group (Fig. 7). Moreover, T-test for comparison of pooled data mean was introduced to analyze our results. The results (P = 0.036) indicate that in the case of a probability of error of less than 5%, there is a significant difference between the experimental group (CrpP+) and the control group (CrpP-). Thus, we can come to the conclusion that CrpP has the capability of degrading CIP.
CrpP -: E.coli DH5α (piGEM2019-01, without crpP); CrpP +: E.coli DH5α (piGEM2019-01 + piGEM2019-02, expressing CrpP enzyme)
Expression verification of CrpP
Although we used statistical methods to test the function of CrpP, we did not get the desired effect directly, so we decided to verify the expression of CrpP. We treated E.coli DH5α (piGEM2019-01 + piGEM2019-02) according to the procedure mentioned in section Degradation of CIP by CrpP (HPLC-UV). As shown in Fig. 8a, we observed one band at 17 kDa corresponding to TagRFP, indicating that the expression system was working. Unfortunately, we couldn’t distinguish the band of CrpP we expected (CrpP expression quantity is low). In order to make CrpP better express, we inserted corresponding sequences into an IPTG induced vector (pEASY) and E.coli BL21 (DE3) was used as host cell. The induction of 0.5 mM IPTG gave rise to the appearance of one band at 17 kDa and no similar bands were detected in control group. The results indicated that CrpP was successfully expressed in E.coli BL21 (DE3) induced by 0.5 mM IPTG.CrpP activity by coupled enzymatic assay
After CrpP was expressed in E.coli BL21 (DE3), we used a coupled enzymatic assay involving NADH oxidation to measure the activity of cell disruption solution on CIP, as described by Víctor M. Chávez-Jacobo [2]. Fig. 9 presented that NADH oxidation rate of the experimental group (0.5 mM IPTG+) , the control group (0.5 mM IPTG-) and the blank group (PBS buffer). When compared with the control and the blank, NADH oxidation rate was significantly increased following the induction of IPTG, indicating that CrpP expressed here can indeed degrade CIP.Quorum sensing system
Next, we used E.coli DH5α co-transformed with piGEM2019-01 and piGEM2019-02 to verify quorum sensing . If it can work, the addition of CIP will induce the expression of TagRFP. As we expected, the bacterial liquid in experimental group turned red (seen from Fig. 10). No similar result was observed in control group.This proves that our quorum sensing system can work normally.Immobilization of bacteria
In addition, we mixed the E.coli bacteria solution carrying piGEM2019-02 with sodium alginate solution, and dropped the mixture into CaCl2 through the needle (Fig. 11) [4]. We successfully immobilized the bacteria.Kill switch
Improve our ciprofloxacin disposal system
1. Enhance the enzyme activity of CrpPAccording to the references, the Km of CrpP is relatively high, indicating the affinity is weak. So, we want to enhance the enzyme activity by site-directed mutation or other methods. As CrpP is a new discovered enzyme, there is a lot of space for improvement.
2. Optimize the expression system
As we want more CrpP enzyme to express, we can enhance PtisAB's response to CIP or just choose a stronger quorum sensing system to enable the expression quantity.
Extend the future market of our hardware
Our device is working normally at present, and we want it to be useful at more situations. In future, we can change PtisAB and CrpP to other specific promoters or genes, so that it can be used to degrade other kinds of antibiotics, and this will help a lot in dealing with the abuse of antibiotics. Besides, it can be better used in larger scenarios, such as sewage plant, laboratory wastewater treatment or pharmaceutical wastewater treatment and so on.Perfect our safety system
Cause our project is based on dealing antibiotics, safety is the prime objective. Although our safety system is working normally, we have to make further improvements to ensure safety. We will continue to work on the blue-light sensitive promoter, using blue light and this promoter to confine our engineered bacteria to our trash can. In addition, we will import a lysin protein with better cell lysis effect to ensure the death of our engineered bacteria cooperating with ultraviolet. In this case, we will do our best to ensure our biosecurity.[2] Chávez-Jacobo, V. M., Hernández-Ramírez, K. C., Romo-Rodríguez, P., et al. (2018). CrpP is a novel ciprofloxacin-modifying enzyme encoded by the Pseudomonas aeruginosa pUM505 plasmid. Antimicrobial agents and chemotherapy, 62(6), e02629-17.
[3] China Medical Science and Technology Press. (2015). Pharmacopoeia of the People's Republic of China, Volume 2. Beijing.
[4] Cho, E., Jang, G., Kim, D., & Lee, T. S. (2017). Fabrication of hollow-centered sodium-alginate-based hydrogels embedded with various particles. Molecular Crystals and Liquid Crystals, 659(1), 71-76.
[5] Wang, G., Lu, X., Zhu, Y., et al. (2018). A light-controlled cell lysis system in bacteria. Journal of industrial microbiology & biotechnology, 45(6), 429-432.
[6] Wang, S., Gu, J., Lv, M. et al. (2017). The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region. Journal of Microbiology, 55: 403.